Copenhagen’s BioInnovation Institute launches 12-month Venture Lab with €500,000 convertible loans for deep tech startups in health, climate, and quantum…
European Biotech Embraces AI to Transform Drug Discovery and Cut Costs
European biotech firms are integrating AI and genomic technologies to reduce RNA sequencing expenses and accelerate pharmaceutical R&D, with Alithea…
Generative AI Accelerates Healthcare Breakthroughs: Enhanced Analysis with Regional Insights and Data
Generative AI is revolutionizing healthcare by accelerating drug discovery and combating antimicrobial resistance, with Asia’s policy-driven initiatives and North America’s…
What the FDA’s zorevunersen delay means for rare disease therapy approvals
The FDA’s September 2023 delay of expedited filing for zorevunersen, a Dravet syndrome treatment, underscores evidence-based regulatory rigor. This analysis…
European Tech Hits Record $45.8B Funding in 2025, Led by AI and Defence Innovations
European startups raised $45.8 billion in 2025, driven by AI, defence tech, and deep tech sectors, signaling Europe’s emergence as…
AI Empowers Small Biotech Startups in Pharmaceutical Innovation
Artificial intelligence is transforming the pharmaceutical industry by enabling small biotech firms to accelerate drug discovery and challenge big pharma…
Scaleup Europe Fund Targets €5 Billion to Fortify Tech Sovereignty
The Scaleup Europe Fund, backed by investors like the Wallenberg family, aims to provide €5 billion in late-stage capital for…
European Healthtech Investments Surge as Startups Drive Medical Innovation
Venture capital is flooding into Europe’s healthtech and biotech sectors, with recent funding rounds like Cellcolabs’ $12 million raise accelerating…
European biotech secures $80 million to advance AI-driven cancer drug discovery
CHARM Therapeutics’ Series B funding highlights Europe’s growing leadership in AI-powered drug development, focusing on novel oncology treatments using advanced…
TrialMatch: The AI-Powered Solution Slashing Clinical Trial Recruitment Timelines
An AI platform that matches eligible patients with clinical trials by analyzing medical data, cutting recruitment time by 40% and…
European tech investment shifts focus to profitability amid global uncertainty
H1 2025 sees 30% YoY capital decrease in European tech investment, with VCs prioritizing profitability over growth. Resilient sectors include…
Epigenica Accelerates Global Expansion Following $15M Series A Funding
Epigenica’s EpiFinder platform demonstrates rapid commercialization with North American and APAC market entries within 30 days of $15M funding, while…